GlassScriptPhysician profile
Priyesh Ashok Patel
NPI 1083858047
$11,013.51
in general payments reported to CMS, 2019-2025
18 companies · $4,891 in 2025
The $4,891 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $893 · 2020: $1,435 · 2021: $1,847 · 2022: $836 · 2023: $587 · 2024: $524 · 2025: $4,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,550 · Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,550.00 |
| Food and Beverage | $1,451.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $5,010.15 | 2022-2025 | Assure Wcd |
| Abbott Laboratories | $3,379.68 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $1,162.98 | 2021-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $822.16 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.68 | 2019-2022 | |
| Cvrx, INC. | $59.24 | 2019-2023 | Barostim Neo System |
| Abbvie INC. | $57.32 | 2025 | |
| Boston Scientific Corporation | $56.39 | 2019 | |
| Impulse Dynamics (USA) INC. | $42.43 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $35.31 | 2022-2023 | Verquvo |
| Endotronix, INC. | $34.84 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Vifor Pharma, INC. | $33.64 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.33 | 2022-2023 | Camzyos |
| Novo Nordisk INC | $21.90 | 2023 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $21.69 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $21.21 | 2020 | |
| Abiomed | $19.08 | 2025 | |
| Medtronic Vascular, INC. | $16.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.